Opponents of a much-contested set of stem-cell patents are claiming victory with a decision from the US Patent and Trademark Office (USPTO), which declared one of the three patents invalid.
Office of Strategic Communication
Opponents of a much-contested set of stem-cell patents are claiming victory with a decision from the US Patent and Trademark Office (USPTO), which declared one of the three patents invalid.